跳至主要内容
临床试验/CTRI/2025/11/096819
CTRI/2025/11/096819尚未招募不适用

Evaluation of the effect of the timing of interval laparoscopic cholecystectomy on intra-operative and post-operative outcomes of patients with choledocholithiasis.

Datta Meghe Institue Of Higher Education and Research1 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2025年11月12日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
26
试验地点
1
主要终点
This study will help to determine optimal timing between ERCP stenting and interval cholecystectomy in order to improve the intra-operative and post operative outcomes and to reduce the risk of recurrent biliary events.

研究概览

简要总结

The common bile duct (CBD) and gallbladder stones are found together in 10-18% of individuals . Among these, 50% to 55% are symptomatic, and approximately 25% experience complications of choledocholithiasis, with pancreatitis and cholangitis representing the most severe manifestations. The primary approach to treating the combination of gall bladder and common bile duct stones consists of removing CBD stones and performing cholecystectomy. To evaluate the effect of the timing of interval laparoscopic cholecystectomy on intra-operative and post-operative outcomes of patients with choledocholithiasis.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • All individuals between 18 to more than 65 years of age with choledocholithiasis and cholelithiasis diagnosed on the basis of ultrasonography, CECT or MRCP All individuals undergoing interval cholecystectomy after ERCP stenting.
  • All individuals who come under ASA grade 1 and
  • All individuals with choledocholithiasis with or without cholelithiasis with or without cholangitis who underwent ERCP stenting, cholecystectomy and stent removal.
  • All individuals who are consenting for study.

排除标准

  • All individuals who lost to follow up.
  • Failure of CBD stone clearance during ERCP.
  • Malignancy or primary sclerosing cholangitis.
  • Patients with Severe liver or kidney dysfunction Patients who underwent previous upper abdominal surgeries.
  • Patients who are unfit for general anaesthesia Patients who underwent cholecystectomy before ERCP Patients who have Mirizzi syndrome All individuals who are not consenting.

结局指标

主要结局

This study will help to determine optimal timing between ERCP stenting and interval cholecystectomy in order to improve the intra-operative and post operative outcomes and to reduce the risk of recurrent biliary events.

时间窗: 2 years

次要结局

未报告次要终点

研究者

发起方
Datta Meghe Institue Of Higher Education and Research
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Prabakaran v

Datta Meghe Institue Of Higher Education and Research

研究点 (1)

Loading locations...

相似试验